We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current SCPH market cap is 169.1M. The company's latest EPS is USD -1.5202 and P/E is -3.09.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 2.06M | 1.64M | 3.8M |
| Operating Income | -9.99M | -9.5M | -11.55M | -13.75M | -14.84M |
| Net Income | -10.16M | -9.25M | -11.21M | -14.15M | -15.63M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 13.59M |
| Operating Income | -32.91M | -29.93M | -25.82M | -36.16M | -55.4M |
| Net Income | -33M | -32.21M | -28.03M | -36.84M | -54.81M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 48.4M | 124.2M | 127.37M | 114.17M | 106.1M |
| Total Liabilities | 17.29M | 51.76M | 51.56M | 50.74M | 56.96M |
| Total Equity | 31.11M | 72.43M | 75.81M | 63.43M | 49.15M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 77.28M | 109.05M | 79.04M | 124.2M | 94.48M |
| Total Liabilities | 25.92M | 26.88M | 22.57M | 51.76M | 57.26M |
| Total Equity | 51.37M | 82.17M | 56.47M | 72.43M | 37.22M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -22.74M | -34.58M | -16.49M | -30.64M | -44.09M |
| Investing | -2.87M | -45.86M | 7M | 16.43M | -6.5M |
| Financing | -7.37M | 77.23M | 13.7M | 14.32M | 14.38M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -30.44M | -27.69M | -27.15M | -34.58M | -59.24M |
| Investing | N/A | -33.46M | 32.13M | -45.86M | 19.97M |
| Financing | 13.59M | 60.35M | -2.53M | 77.23M | 14.85M |
| Market Cap | 169.1M |
| Price to Earnings Ratio | -3.09 |
| Price to Sales Ratio | 12.44 |
| Price to Cash Ratio | 3.61 |
| Price to Book Ratio | 4.54 |
| Dividend Yield | - |
| Shares Outstanding | 36.05M |
| Average Volume (1 week) | 154.48k |
| Average Volume (1 Month) | 154.07k |
| 52 Week Change | -57.59% |
| 52 Week High | 12.75 |
| 52 Week Low | 4.25 |
| Spread (Intraday) | 1.64 (28.32%) |
| Company Name | scPharmaceuticals Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.scpharmaceuticals.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
